Guido Gerken

Guido Günther Heinrich Gerken (born August 7, 1952 in Mendig , Mayen-Koblenz district ) is a German gastroenterologist and hepatologist .

Life

After completing his school education and obtaining his university entrance qualification in 1971, he began studying human medicine at Johannes Gutenberg University in Mainz. He received his license to practice medicine in 1977.

For medical doctor doctorate Guido Gerken also in 1977 with magna cum laude . In the same year he was employed in the Maria-Hilf Hospital in Bad Neuenahr in the department for anesthesiology and in the department for surgery. He worked there until 1979. From 1979 to 1981 he practiced as an assistant at the Neustadt district hospital in the Hanover district and as an assistant in a country doctor's practice in Mendig / Eifel and Betzdorf / Sieg.

In 1981 he began his scientific career as an assistant at the First Medical Clinic and Polyclinic of Johannes Gutenberg University Mainz. There he received the specialist certification for internal medicine in 1987. From 1988 to 1989 he completed a research assignment in the Department of Molecular Biology and Hepatocarcinogenesis at the Pasteur Institute in Paris. In the following year, Guido Gerken received the license to teach internal medicine ( Venia Legendi ) at the University of Mainz . His habilitation thesis from that year was entitled “The importance of the polymerase chain reaction (PCR) for the characterization of hepatis B virus-associated liver diseases”. He also became a senior physician at the I Medical Clinic and Polyclinic of the Johannes Gutenberg University.

In 1992 he was appointed to a C2 professorship for a limited period at Johannes Gutenberg University. In 1996 he was appointed associate professor . His branch was gastroenterology. From 1995 to 1998 he worked as a senior consultant at the I Med. Clinic and Polyclinic of the Johannes Gutenberg University Mainz. In 1998 he was offered a C 4 professorship as professor of gastroenterology and hepatology at the Essen University Hospital . There he was Deputy Managing Director of the Center for Internal Medicine from 2000 to 2001. From 2001 to 2002 he was the managing director of the center. In May 2007 he was appointed Executive Director of the Center for Internal Medicine by the UK Board of Directors. In addition to these tasks, he became a member of the ethics committee of the Essen University Hospital in 2003 and a member of the Research Committee of the Essen University Hospital in 2004. In 2008 he was appointed to the supervisory board of the Medical Faculty of the University Hospital Essen. Gerken is also a member of around two dozen international specialist societies. He works as an author and reviewer for the German Medical Weekly (DMW). Guido Gerken is an advisory board member of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS). Guido Gerken retired in February 2018.

Research profile

Research profile clinical gastroenterology: acute and terminal liver failure. In particular, molecular-biological pathomechanisms for acute liver failure and the fibrosis progression of chronic liver diseases; Evaluation of the mini-laparoscopy in the diagnosis of chronic liver diseases and tumor diseases; Regional, national and international clinical studies; Use of innovative therapy methods for functional gastrointestinal diseases, chronic inflammatory bowel diseases (Crohn's disease, ulcerative colitis), autoimmune hepatitis, viral hepatitis B and C and HIV co-infection and hepatocellular carcinoma, establishment of biomarkers in gastroenterology.

Clinical basics in gastroenterology: Molecular biological pathomechanisms and genetic studies of non-alcoholic fatty liver (NAFL) in particular the progressive form of non-alcoholic steatohepatitis (NASH), role of apoptosis (programmed cell death) and fibrogenesis, pathogenetic aspects of cholangiocellular carcinoma. Research projects on the use of new immunosuppressants are carried out on an interdisciplinary basis with transplant surgery, immunology, virology and nephrology (DNA, peptide, T-cell vaccines). Using the example of chronic inflammatory colitis (IBD), the cellular and immunological basis of inflammation in Crohn's disease and ulcerative colitis is characterized.

Memberships since

• 1984: Member of Dt. Society for Internal Medicine (DGIM)
• 1985: Member of Dt. Society for the Study of the Liver (GASL)
• 1986: Rhineland-Palatinate. Working Group for Gastroenterology (GARP)
• 1986: Member of Dt. Society for Digestive and Metabolic Diseases (DGVS)
• 1998: Extraordinary member of the Drugs Commission of Dt. Medical profession
• 2008: Member of IASL (International Association for the Study of Liver)
• 2009: Associate member of the German Liver Foundation
• Chairman of the board of the Society for Gastroenterology in North Rhine-Westphalia eV
• as well as other memberships and functions

Awards

• 1989: "Prix jeunes chercheurs" of the French Society for the Study of the Liver (L'AFEF)
• 1989: Asche research grant from DGVS
• 1992: Annual award from the Dr. Carl Duisberg Foundation
• 1992: Albert Knoll Prize

Fonts

• Doctoral thesis: "On the development of clinical drug testing on humans in the 19th and 20th centuries", Johannes Gutenberg University, Mainz, Medical History Institute (Director G. Mann)
• Habilitation thesis: "The importance of the polymerase chain reaction (PCR) for the characterization of hepatis B virus-associated liver diseases"
• as well as a wealth of other publications in specialist journals

Web links

• Literature by and about Guido Gerken in the catalog of the German National Library
• Curriculum Vitae at the University Hospital Essen
• WHO'S WHO
• GASL annual conference 2017

Individual evidence

1. ↑ German Medical Weekly (DMW) 2013; 138; No. 36
2. ↑ Liver expert retires
3. ^ Society for Gastroenterology in North Rhine-Westphalia eV
4. ↑ Albert Knoll Prize ( Memento from January 11, 2015 in the web archive archive.today )